Northwest Biotherapeutics Revenue (TTM) Analysis

Northwest Biotherapeutics Inc (NWBO)

0.477 +0.02 (+3.67%) USD | OTCM | Apr 25, 16:00

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	1.932M
September 30, 2023	2.084M
June 30, 2023	1.884M
March 31, 2023	2.16M
December 31, 2022	1.683M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021	1.508M
June 30, 2021	1.374M
March 31, 2021	0.96M
December 31, 2020	1.291M
September 30, 2020	1.685M
June 30, 2020	2.062M
March 31, 2020	2.641M
December 31, 2019	2.41M
September 30, 2019	1.062M
June 30, 2019	0.922M
March 31, 2019	0.619M
December 31, 2018	0.412M
September 30, 2018	0.895M
June 30, 2018	0.59M
March 31, 2018	0.40M
December 31, 2017	0.336M

Date	Value
September 30, 2017	0.375M
June 30, 2017	0.386M
March 31, 2017	0.455M
December 31, 2016	0.623M
September 30, 2016	1.415M
June 30, 2016	1.547M
March 31, 2016	1.781M
December 31, 2015	1.739M
September 30, 2015	1.748M
June 30, 2015	2.039M
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013	1.131M
June 30, 2013	0.851M
March 31, 2013	0.909M
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

0.922M

Minimum

Jun 2019

2.641M

Maximum

Mar 2020

1.710M

Average

1.685M

Median

Sep 2020

Revenue (TTM) Benchmarks